Mohammad Rashidian

Dr. Rashidian's research focuses on leveraging protein engineering to create novel imaging probes and immunotherapies for cancer and autoimmune diseases. These imaging probes have the potential to aid in the diagnosis of challenging conditions like myocarditis or unexplained fevers. A specific area of interest is the development of immunotherapies aimed at guiding cellular therapies, such as CAR T or NK cells, toward the formation of enduring memory cells. Mohammad's multidisciplinary interests encompass immunology, imaging, protein engineering, and chemical biology. He initiated the lab at Dana-Farber Cancer Institute in the summer of 2019.